Chemo Hierarchy and Injection/Infusion Complexity

The complexity of infusion therapy rule-sets is a challenge for even the most experienced clinicians. Applying these rule-sets is an error-prone task, and is the primary reason  for increased payer scrutiny of treatment center charges. The need has never been greater for accurate and defensible charging of the chemotherapy agents and therapeutic/diagnostic infusion procedures.

LYNX I/Point™ provides hospital-owned infusion and oncology treatment centers with an intuitive user interface that enables clinicians to focus simply on recording the basic elements of the infusion, freeing them up to do more of what they do best — provide exemplary patient care. Combined with the LYNX chemotherapy infusion algorithm and advanced drug formulary, I/Point’s infusion services module supports the complex charging rules for the administration of chemotherapy agents. As a result, I/Point provides compliant and defensible charging for the chemotherapy hierarchy and therapeutic diagnostic infusion procedures, meets payer infusion charging requirements and  provides a strong defense for audits with compliant intravenous services charging.